Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
Micardis(R) - MicardisPlus(R) - Hypertonie (38 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Zum ersten Bild Abb. 22: Blutdrucksenkung - Zielorganschäden Abb. 23: Blutdrucksenkung - Vorteile Abb. 24: Antihypertensive Behandlungsziele Aktuelles Bild - Abb. 25: Behandlungsschema - JNC 7 Abb. 26: Behandlungsschema - ESH-ESC Abb. 27: Hypertonie - Bewußtsein Abb. 28: Morgendlicher Blutdruck Zum letzten Bild
Abbildung 25: Behandlungsschema - JNC 7
This is a section of the full treatment algorithm, focussing on the choice of antihypertensive class.1 The JNC 7 guidelines recommend lifestyle modifications as an intervention in all patients.1 Patients with Stage 2 hypertension (SBP/DBP ≥160/≥100 mmHg) should receive initial therapy with combination treatment.1 Although diuretics are the drugs of choice for uncomplicated hypertension, the presence of ‘compelling indications’ (see next slide) can dictate the initial use of other drug classes.1 1. Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560–2572.
 
Behandlungsschema - JNC 7
Vorheriges Bild Nächstes Bild   


Abbildung 25: Behandlungsschema - JNC 7
This is a section of the full treatment algorithm, focussing on the choice of antihypertensive class.1 The JNC 7 guidelines recommend lifestyle modifications as an intervention in all patients.1 Patients with Stage 2 hypertension (SBP/DBP ≥160/≥100 mmHg) should receive initial therapy with combination treatment.1 Although diuretics are the drugs of choice for uncomplicated hypertension, the presence of ‘compelling indications’ (see next slide) can dictate the initial use of other drug classes.1 1. Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560–2572.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung